(Q34124235)
Statements
1 reference
U.S. Food and Drug Administration approval: ofatumumab for the treatment of patients with chronic lymphocytic leukemia refractory to fludarabine and alemtuzumab (English)
1 reference
Steven J Lemery
1 reference
Jenny Zhang
1 reference
Mark D Rothmann
1 reference
Jun Yang
1 reference
Justin Earp
1 reference
Hong Zhao
1 reference
Andrew McDougal
1 reference
Anne Pilaro
1 reference
Raymond Chiang
1 reference
Joseph E Gootenberg
1 reference
Patricia Keegan
1 reference
Richard Pazdur
1 reference
2 July 2010
1 reference
1 reference
16
1 reference
17
1 reference
4331-4338
1 reference
Identifiers
1 reference
1 reference